Which is the optimal immunotherapy for advanced squamous non-small-cell lung cancer in combination with chemotherapy: anti-PD-1 or anti-PD-L1?

Name: Which is the optimal immunotherapy for advanced squamous non-small-cell lung cancer in combination with chemotherapy: anti-PD-1 or anti-PD-L1?
Author: Zhang, Yaxiong

Which is the optimal immunotherapy for advanced squamous non-small-cell lung cancer in combination with chemotherapy: anti-PD-1 or anti-PD-L1? — المؤلف: Zhang, Yaxiong — Journal for immunotherapy of cancer 20191016

المؤلف: Zhang, Yaxiong
النشر: Journal for immunotherapy of cancer 20191016
الوصف: 135 p.
الموضوعات: Adult؛ Aged؛ Aged, 80 and over؛ Antibodies, Monoclonal؛ Antibodies, Monoclonal, Humanized؛ Antineoplastic Agents, Immunological؛ Antineoplastic Combined Chemotherapy Protocols؛ B7-H1 Antigen